MRTFA and gastric carcinoma: Higher MKL1 expression was indicated in cholangiocarcinoma, esophageal carcinoma, head-and-neck squamous cell carcinoma, kidney chromophobe, liver hepatocellular carcinoma, and stomach carcinoma (Figure 1A and B).